Main > A1. CORP. INDEX. Rn-Rz > Roche /P C2
This data is not available for free
Roche /P C2's subsections
2000. 12.07.2000. (Oncology)
2002. 05.20.2002. (Depression)
2002. 07.01.2002. (AD)
2002. 07.22.2002. (Influenza..)
2002. 09.30.2002. (Oncology)
2002. 10.21.2002. (Supplier)
2002. 12.02.2002. (Genomics)
2003. 01.06.2003. (Oncology)
2003. 01.27.2003. (Oncology)
2003. 02.10.2003. (Hematology)
2003. 02.17.2003. (Business Sale)
2003. 02.17.2003. (Executive)
2003. 02.17.2003. (Parent of)
2003. 02.24.2003. (IFN-Alpha)
2003. 02.24.2003. (Oncology)
2003. 04.07.2003. (Animal Nutr.)
2003. 05.05.2003. (SARS)
2003. 05.19.2003. (Malaria/Ranbaxy)
2003. 05.26.2003. (Hepatology)
2003. 09.16.2003. (Diab/Alliance)
2003. 09.18.2003. (CNS/Alliance)
2003. 11.10.2003. (Antibiotics)
2003. 12.08.2003. (Stressgen Deal)
2004. 01.13.2004. (Igen Acq.)
2004. 01.26.2004. (R&D/China)
2004. 02.16.2004. (Diabetes)
2004. 03.25.2004. (Evotec Neuro..)
2004. 11.19.2004. (Business Sale)
2004. 12.31.2004. (Oncology)
2005. 01.10.2005. (OTC Business)
2005. 07.05.2005. (Emisphere Tech.)
2005. 07.05.2005. (Influenza)
2006. 03.20.2006. (Influenza)
2006. 05.08.2006. (Borean Pharma)
2006. 05.09.2006. (Blood Coag.)
2006. 07.17.2006. Actelion
2006. 07.19.2006. Ipsen Diabetes
2006. 12.06.2006. (Halozyme)
2007. 06.25.2007. (Rheumatoid A.)
2007. 07.16.2007. (RNAi)
2007. 11.02.2007. Hepato.>HCV>Poly
2007. 11.15.2007. (Anemia Drug)
2007. 12.03.2007. (Pres. & CEO)
2008. 02.11.2008. Personalized Med.
2008. 03.04.2008. Chairman
2008. 10.20.2008. Diabetes
2008. 10.20.2008. Sr Research Lead
2009. 05.11.2009. CEO
2009. 08.31.2009. Lonza
2010. 04.13.2010. Corp. Acq.
2011. 10.11.2011. DNA Sequencing
2011. 11.29.2011. PTC Therapeutics
2011. 12.02.2011. Corp. Acq.
2012. 01.11.2012. Diabetes
2012. 01.19.2012. Technoclone
2012. 02.01.2012. Chlamydia &
2012. 02.20.2012. Onco.>Melanoma
2012. 03.30.2012. FDA Approval
2012. 05.07.2012. CV.>Dalcetrapib
2012. 06.03.2012. Onco.>Colon C.
2012. 06.07.2012. CV.>MI Diag.
2012. 06.19.2012. Seaside Therap.
2012. 06.26.2012. StreamLine R&D
2012. 07.19.2012. Endo.>Diabetes
2012. 07.26.2012. Vit. D Lab. Test
2012. 07.27.2012. Areva Med
2012. 09.04.2012. Herpes Diag.
2012. 09.20.2012. TCRC
2012. 09.24.2012. Galaxy Biotech
2012. 10.01. Onco.>Breast C. T IV
2012. 10.03.2012. AIDS
2012. 11.28.2012. Broad Institute
2012. 12.12.2012. Invest 240 M
2012. 12.22.2012. Influenza
2013. 01.15.2013. Exec. Committee
2013. 02.18.2013. Chiasma
2013. 03.06.2013. Hepato.>HCV>Diag
2013. 03.18.2013. Hepato.>HCV>IFN+R
2013. 04.04.2013. Onco.>Thyroid C.
2013. 04.23. Diag. ReStructure
2013. 05.15. Onco.>NSCLC E
2013. 05.23. Endo.>Diabetes>Diag.
2013. 06.17. Onco.>Brain C.
2013. 07.02. Onco.>Breast C. P
2013. 07.02. Roche Diag. Acq.
2013. 07.10. Diab.>Aleglitazar
2013. 08.05. Medicines Patent Pool
2013. 09.02. Onco.>Breast C. T SC
2013. 10.14. Invest in Biologics
2013. 10.22. Rheuma.>RA
2013. 11.04. Polyphor
2014. 01.21. Neuro.>Schizophrenia
2014. 01.30. 2013 Results
2014. 03.05. Pneumo.>Asthma
2014. 04.07. Acq. IQuum Inc.
2014. 04.07. Oryzon Genomics SA
2014. 04.25. Onco.>Cervical C.
2014. 06.02. Acq Genia Technologies
2014. 07.04. Onco.>NSCLC A
2014. 07.29. MMD 1>AmorChem
2014. 07.29. Onco.>CLL
2014. 08.04. Acq. Santaris Pharma.
2014. 08.06. Onco.>Ovarian C.
2014. 11.05. Invests in CN
2014. 11.13. Strep A Test
2014. 12.02. Acq Ariosa Diagnostics
2014. 12.18. Acq Dutalys GmbH
2015. 01.09. Diag. HBV; HCV & HIV
2015. 01.12. Foundation Medicine
2015. 01.16. Acq Trophos
2015. 01.26. Diag. MRSA/SA
2015. 01.29. Qualcomm
2015. 02.09. Acq Signature Diag.
2015. 07.31. Onco.>Breast C.
2015. 08.13. Acq. GeneWeave Bio
2015. 08.19. Acq. Kapa Biosystems
2015. 12.01. Upsher Smith
2016. 06.08. Onco.>NSCLC E+B
2016. 06.16. Follicular Lymphoma
2016. 08.29. Zika PCR Test
2016. 10.19. Onco.>Lung C.
2016. 11.15. Cancer Network
2017. 01.19. Cardio.>Heart Attack
2017. 04.18. Onco.>Bladder C.
2017. 04.18. Ophthalmo..>Diabetic R
2017. 11.17. Acq. Viewics Inc.
2018. 04.04. Inception Neuroscience
2018. 09.27. Acq. Tusk Therapeutics
2019. 06.18. Onco.>NTRK+Solid>JP>OK
2019. 08.16. Onco.>NSCLC>MET>ROS1-+
2019. 08.16. Onco.>NTRK+Solid>US>OK
2019. 12.05. detect MRSA bacteria
2019. 12.17. Acq. Spark Therapeutic
2019. 12.23. DMD Sarepta Ex. USA
2020. 03.19. COVID-19 Treat.
2020. 04.17. COVID-19 ABs.
2020. 05.03. COVID-19 ABs. USA>EUA
2020. 05.22. Acq. Stratos Genomics
2020. 06.04. USA>EUA>IL-6 test
2020. 06.19. Onco.>FL
2020. 06.29. Onco.>Breast C.
2020. 07.20. Neuro.>AD>Ab.>UCB
2020. 09.21. Acq. IE>Inflazome Ltd.
2020. 10.07. Enterprise Therapeutic
2020. 10.19. Onco.>AML
2020. 10.22. COVID-19 Treat.
2020. 10.29. Onco.>Liver C.>CN
2020. 12.23. Onco.>Breast C.>EU>OK
2021. 02.11. transplant patients
2021. 03.15. Acq. GenMark Diag.
2021. 06.28. Neuro/Ophthalmo>NMOSD
2021. 08.24. Shape Therapeutics
2022. 05.31. SMA Babies<2 USA>OK
2022. 08.12. Influenza>USA>OK
2023. 12.03. Acq. Carmot Therapeuti
2023. 12.14. Acq. Telavant
2024. 01.16. EU CE Mark
Hoffmann La Roche Inc/P C2
Roche Colorado Corp./P C2
Roche Diagnostics/P C2
Roche NimbleGen Inc./P C2
Roche Palo Alto LLC /P C2
Roche Sequencing./P C2
Roche Venture Fund. C2
Web-Site
Z - OK
Roche /P C2's products
This section has no products